About Us
Services
Therapeutic Area Expertise
Devices
Data Management
Max Neeman Differentiators
Careers
Contact Us
Top Links
About Us
Services
Max Neeman Differentiators
Therapeutic Area Expertise
Data Management
Careers
Contact Us
Devices
Bottom Links
Testimonials
Max Neeman SOPs
Links
FAQs
Site Map
Max Neeman Mails
Training Presentation
Knowledge Management
Contact For Feasibility
Discussion Forum
Disclaimer
Privacy Policy
Upcoming Conferences
Rescue Studies
The Parent Company - Max
Clinical Trial Registration - India
Neeman & Industry News
DCGI to implement e-Gov in its working
The Drugs Controller General of India (DCGI) to have a single window facility for drug approval soon...
New Indian Regulatory Guidance by Central Drugs Standard Control Organization
Guidance for Industry on Submission of Clinical Trial Application for Evaluating Safety and Efficacy - Central Drugs Standard Control Organization...
Indian Clinical Data Management market is expected to ramp up to $150 million
MNCs are more than willing to outsource their needs to India because of it\'s technological innovation, creditable quality, operational flexibility, cost effectiveness, time-to-market and competitive advantage according to Koteshwar Govind, Deputy Manager,...
India: Attractive Market for Biopharmaceutical Companies Looking to Accelerate Their Clinical Trials
The Clinical Research Market in India is growing at a very rapid rate according to anyone’s statistics…It is exploding according to all the hype. ...
more...
Subscribe News Letter
Name*
Mr
Mrs
Ms
Dr
Designation
Company Name*
Email*
Office Address Line 1*
Office Address Line 2
:
Office Address Line 3
City*
State
Country*
Afghanistan
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegowina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Cook Islands
Costa Rica
Cote D'Ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
France, Metropolitan
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guinea
Guinea-bissau
Guyana
Haiti
Heard and Mc Donald Islands
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran (Islamic Republic of)
Iraq
Ireland
Israel
Italy
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russian Federation
Rwanda
Saint Kitts and Nevis
Saint Lucia
Saint Vincent and the Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Senegal
Seychelles
Sierra Leone
Singapore
Slovakia (Slovak Republic)
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
St. Helena
St. Pierre and Miquelon
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan
Tajikistan
Tanzania, United Republic of
Thailand
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Vatican City State (Holy See)
Venezuela
Viet Nam
Virgin Islands (British)
Virgin Islands (U.S.)
Wallis and Futuna Islands
Western Sahara
Yemen
Yugoslavia
Zaire
Zambia
Zimbabwe
Pin/Zip Code*
Phone
(Country - Area - Telephone No.)
Fax Number
(Country - Area - Telephone No.)
Website
Your Job Function/Job Title:
----------------Select----------------
Corporate Management
Senior Management
Scientific Research Mgt
Middle Mgt
Non - Managerial
Others
Others please specify:
Your organization business:
------------------Select------------------
Bio - Technology
Pharma
Medical - Technology
Bio - Informatics
Bio - Logicals
Distributor / Dealer / Supplier
Research / Training / Education Institute
Government
Genetics
Health Care
Legal Services / Patent Services
Media / Event Organisors
Venture Capitalist / Investor
Others
Others please specify:
How many employees are there in your organization:
-----------------------Select-----------------------
Less Than 50
50 to 100
100 to 500
500 to 1,000
1,000 and Above
Total revenue of your organization:
-----------------------Select-----------------------
Less Than A Million
1 to 10 Million
10 to 50 Million
50 to 99 Million
100 to 500 Million
500 Million and More
www.maxindia.com
Testimonials
|
Max Neeman SOPs
|
Links
|
FAQs
|
Site Map
|
Max Neeman Mails
|
Training Presentation
|
Knowledge Management
|
Contact For Feasibility
|
Discussion Forum
© Copyright 2008 Max Neeman. All Rights Reserved.
Disclaimer
|
Privacy Policy
Powered By:
SWTGROUP